吉林敖东(000623.SZ)子公司取得升陷汤颗粒药品注册证书

Core Viewpoint - Jilin Aodong (000623.SZ) announced that its subsidiary, Jilin Aodong Taonan Pharmaceutical Co., Ltd., received the "Drug Registration Certificate" for "Shengxian Decoction Granules" from the National Medical Products Administration [1] Group 1 - The "Shengxian Decoction Granules" are indicated for the treatment of Qi deficiency syndrome, characterized by symptoms such as shortness of breath, difficulty in breathing, and weak pulse [1] - The product is specifically used for conditions related to "Qi sinking" [1]